Automated measurement of 25-OH Vitamin D on the LUMIPULSE® G1200: analytical validation and method comparison

Author:  Laura Foj; Marina Parra and Xavier Filella - Department of Biochemistry and Molecular Genetics. Hospital Clínic - Barcelona - Spain

Clinical interest in 25-OH Vitamin D has increased exponentially because of its usefulness in several pathologies, particularly in bone diseases. However, standardisation of assays remains a significant problem. Our laboratory has extensive experience in the development, evaluation and implementation of Vitamin D assays. With this background, we evaluated the performance of the novel Lumipulse® G 25-OH Vitamin D assay (Fujirebio), comparing results with a conventional assay (CLIA). This new assay is different from the current ones available on the market because it is the only method using a sandwich immunoassay instead of a competitive immunoassay approach and due to its unique VDBP release method (substitution instead of pretreatment method).

We tested randomly collected sera from 226 patients, covering the measuring range of 4-150 ng/mL. Both assays were compared using a proficiency panel of 20 samples (Labquality, Bioclin laboratory, Helsinki, Finland) that was quantified for 25-OH Vitamin D concentrations using Ghent University ID-LC/MS-MS (Reference Measurement Procedure). In addition, we compared the performance of the Lumipulse G and conventional CLIA assays with a VDSCP aligned LC-MS/MS in 20 routine samples.

The outcome of the evaluation was:

  • Correlation between both commercial methods Liaison and Lumipulse G was high, with a correlation coefficient on 0.934 for all samples.
  • The Lumipulse G 25-OH Vitamin D assay showed better correlation than the conventional CLIA assay with the LC/MS-MS reference method, being an accurate and precise automated tool for serum 25-OH Vitamin D measurements.
  • The LUMIPULSE system was very easy to use and it demonstrated to be a very robust instrument, fulfilling the requirements for installation in clinical routine laboratories.

Laura Foj, Marina Parra and Xavier Filella
Department of Biochemistry and Molecular Genetics. Hospital Clínic, Barcelona


You can change the country filter for contents in our website. You will then see local contact information and other information available for that country. Please choose your country in the list below:

Please log in to react

Welcome to Fujirebio

It looks as if you are visiting from the United States. The content of this website is not destined for United States visitors.

If you continue your visit you confirm that you understand that not all of the products you will see listed are FDA cleared. FDA cleared products may not be cleared for all indications mentioned on this site. Product claims may differ from country to country based on regulations and approvals.

Please contact your country representative for further details.